OTT: Annual Celebration: 2022 Start-Up of the Year @emoryuniversity
OTT: Annual Celebration: 2022 Start-Up of the Year  @emoryuniversity
Uploaded May 2022 | Updated November 2026, 8 hours ago
START-UP OF THE YEAR
CAMBIUM MEDICAL TECHNOLOGIES – PREPARATION AND USAGE OF HEPARIN- CONJUGATED FIBRINOGEN DEPLETED POOLED HUMAN PLATELET LYSATE FOR REGENERATIVE MEDICINE
EDMUND WALLER, MD, PHD; JOHN ROBACK, MD, PHD
Cambium Medical Technologies was founded in 2013 by four professionals from Emory University. They are focused on developing and commercializing regenerative therapeutics created from novel processed human platelets. Since the licensing of Emory technology “Preparation and Usage of Heparin- Conjugated Fibrinogen Depleted Pooled Human Platelet Lysate for Regenerative Medicine” in 2014, Cambium Medical Technologies has successfully completed a Phase I/II FDA dry eye clinical study for their product Elate Ocular®. In 2021, Cambium received approval from the FDA to begin two Phase III clinical trials for their dry eye biologic.

More information: https://www.ott.emory.edu/about/annual-celebrations/index.html
OTT: Annual Celebration: 2022 Start-Up of the YearAfter four years at Emory—Glambot Cam for the Class of 2026OTT: Revenue Sharing FAQGary Motley, Jazzmeia Horn, Dwight Andrews and Sam Yi, moderated by WCLK jazz radio host Debb MooreOTT: Annual Celebration: 2022 IDEAwardOTT: 40 Years of Emory Technology TransferFeels like summer here. See Emory through the seasons.The Many Lives of Andrew Young: A Conversation with Andrew Young and Ernie Suggs (Emory University)Emory Faculty Orientation VideoCreativity Conversation with Natasha Trethewey and Fintan O’Toole#Classof2026 Then and Now—Look how far you’ve come! 💙 🦅 🎓 💛 #FlyHigherEmory Early Decision I 2023
Emory University |

OTT: Annual Celebration: 2022 Start-Up of the Year

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER